EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination.
Brand(s)
Summary
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot number |
|---|---|---|---|---|---|
Pfizer |
EPINEPHRINE INJECTION USP |
DIN 00710814 |
Intravenous Solution |
EPINEPHRINE 1mg / mL |
LR4585, LN2814, LN2813 & LX1239 |
Pfizer |
SODIUM BICARBONATE INJECTION USP |
DIN 00261998 |
Intravenous Solution |
SODIUM BICARBONATE 84 mg / mL |
LN0968, LP9658, LW7842, LR4597, LN0970, MA4046, MA4048, LY3748, MA8144 & MD0507 |
Pfizer |
DEXTROSE INJECTION USP |
DIN 02468514 |
Intravenous Solution |
Dextrose 500 mg / mL |
LH2756 & LY3589 |
Issue
Affected lots may contain the presence of microbiological contamination.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Pfizer Canada ULC
17300 Trans-Canada Highway
Kirkland, QC
H9J 2M5
Get notified
Receive emails about new and updated recall and safety alerts.